ASCENDIS PHARMA A/S

ASNDNASDAQ

🏆 #482 by market capEarnings Nov 6 · PostUS Equity

$502.66▲ $10.10 (+2.01%)

Simulated price

1h—

24h▲ 2.0%

7d—

14d—

30d—

1y—

🏦Market Cap

$18.41B

Mid Cap

📈Revenue Growth (YoY)

+134.8%

High Growth

📊Gross Margin

89.0%

High

💵FCF Margin

—

⚖️P/S Ratio

16.0x

Expensive

Otter Score

56

Weak

🔭

No analyst ratings for ASND

We don't have Wall Street analyst coverage for this ticker yet. Ratings and price targets appear here as firms publish them.